Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Schering AG acquires Celera Genomics' cathepsin S inhibitor program

June 23, 2006

VEC-162: rapidly shifts circadian phases to improve sleep properties

June 23, 2006

Novel histamine H1 agonist as a clinical candidate for sleep maintenance insomnia

June 23, 2006

Effects of CX-717 on EEG spectra assessed after sleep deprivation

June 23, 2006

Trials further reveal indiplon efficacy and safety in patients with insomnia

June 23, 2006

MBP-8298 delays multiple sclerosis progression in HLA class II subgroup

June 23, 2006

U.K. acute pain study of cannabinor cleared to begin

June 22, 2006

Aeolus selects AEOL-11207 as first development candidate

June 22, 2006

GDNF gene therapy is neuroprotective in Huntington's disease / News in Context

June 22, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

June 21, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...